Stop by booth 641 to meet your next viral vector partner.
Founded in 2014, Genezen is a viral vector CDMO focused on supporting the demands of the cell and gene therapy manufacturing market worldwide — making viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen offers the following capabilities, building on the company's expansive knowledge and experience.
- Process Development
- Analytical Development
- cGMP Viral Vector Manufacturing
- Patient Sample Testing
- Cell Therapy Manufacturing
- Master Cell Bank Production and Expansion